(Q37574457)

21 August 2017

1 reference

title

Functional neurosurgery for movement disorders: a historical perspective (English)

1 reference

21 August 2017

0 references

1 reference

Paul Krack

1 reference

21 August 2017

Pierre Pollak

1 reference

ORCID Public Data File 2021

21 August 2017

Napoleon Torres

1 reference

author name string

Alim Louis Benabid

1 reference

21 August 2017

Stephan Chabardes

1 reference

21 August 2017

Brigitte Piallat

1 reference

21 August 2017

Valerie Fraix

1 reference

21 August 2017

publication date

1 January 2009

1 reference

Progress in Brain Research

21 August 2017

published in

1 reference

21 August 2017

volume

175

1 reference

21 August 2017

page(s)

379-391

1 reference

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Ligation of the anterior choroidal artery for involuntary movements; parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Latest view on the mechanism of action of deep brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Physiological observations in stereotaxic operations in extrapyramidal motor disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Mirthful laughter induced by subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Pallidal deep-brain stimulation in primary generalized or segmental dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

From bench to bed: the potential of stem cells for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Results by motor cortex stimulation in treatment of focal dystonia, Parkinson's disease and post-ictal spasticity. The experience of the Italian Study Group of the Italian Neurosurgical Society.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Electrophysiological and metabolic evidence that high‐frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Therapeutic modulation of synaptic connectivity with desynchronizing brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Protection of nigral cell death by bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

Alteration of hormone and neurotransmitter production in cultured cells by high and low frequency electrical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

1 reference

7 January 2021

Extradural cortical stimulation for movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2809%2917525-8

7 January 2021

10.1016/S0079-6123(09)17525-8

Identifiers

DOI

1 reference

21 August 2017

1 reference